Buy, Sell Or Hold: Swiggy, Vedanta, Paytm, Kansai Nerolac, Fortis Healthcare — Ask Profit
Market analysts shared insights for short-term and long-term investors on whether to buy, sell or hold shares of BASF India, KPIT Technologies, Ceigall India, and Fortis Healthcare, among others.
Should you buy shares of Vedanta Ltd. at the current market price? Is Swiggy Ltd. a good choice from a long-term perspective? Should you keep holding the stock of Paytm parent One 97 Communications Ltd.? Is it the right time to exit Kansai Nerolac Paints Ltd. and book profit?
Girish Sodani, co-founder of Ensure Capital, and Aditya Arora, founder of Adlytick answered these investor queries and more on NDTV Profit's Ask Profit show.
BASF India (CMP: Rs 4,301.1)
Arora: Sell on rise.
Bounce back expected in short-term.
Levels seen on the upside are Rs 4,500-Rs 4,850.
Kansai Nerolac Paints (CMP: Rs 245.16)
Sodani: Buy
Results of paint companies look good for the next two quarters.
Go with long-term propositions.
Ceigall India (CMP: Rs 293.85)
Arora: Sell
Stock inherently lacks strength.
Maintain trading stoploss at Rs 270.
Vedanta (CMP: Rs 444.45)
Sodani: Hold
Positive view for the next three to four years.
More focus on diversification, strong dividend payouts.
Swiggy (CMP: Rs 418.6)
Sodani: Sell on rise
Not bullish on this segment.
Company facing huge losses on operational margins in Tier-2 and Tier-3 cities.
Paytm (CMP: Rs 803)
Sodani: Hold
Heavy competition in the space.
Hold for two-three years.
Hold position with stoploss of Rs 650.
KPIT Technologies (CMP: Rs 1,432.75)
Arora: Sell
Bumpy road ahead for IT sector due to DeepSeek.
Resistance placed in zones of Rs 1,400-1,550.
Fortis Healthcare (CMP: Rs 667.3)
Arora: Buy
Good time to buy.
Levels to watch on upside are Rs 700-Rs 750.
Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.
